Analysis of the Therapeutic Effect of Diyu Shengbai Tablets on Improving Leukopenia Caused by Antipsychotic Drugs
Objective To investigate the efficacy and safety of diyu shengbai tablets and batilol tablets in improving the leukopenia caused by antipsychotic drugs,and evaluate their clinical efficacy.Methods A retrospective study was conducted,60 patients were diagnosed with leukopenia caused by the use of antipsychotic drugs in Jiangxi Mental Health Center from December 2020 to December 2022 were divided two groups.The patients taking diyu shengbai tablets were assigned to the study group,and the patients taking batilol tablets were assigned to the control group,with 30 cases in each group.The clinical efficacy,WBC and incidence of adverse reactions were compared between the two groups before and after treatment for 1 month,2 months.Results The difference in peripheral white blood cell count between patients before and after treatment was statistically significant(P<0.05),but there was no statistically significant difference between 1 and 2 months after treatment(P>0.05).Average total effective rate:the study group was higher than the control group,and the whitening effect of the study group was better than that of the control group at 1 and 2 months after treatment,with a statistically significant difference(P<0.05);the incidence of adverse reactions in the study group was lower than in the control group.Conclusion Diyu shengbai tablets is effective and safe in the treatment of leukopenia caused by antipsychotics.It Provide a suitable treatment plan for leukopenia caused by antipsychotic drugs.
Diyu shengbai tabletsLeukopenia caused by antipsychotic drugsTherapeutic effect analysisAdverse reactions
NETL
NSTL
万方数据
